Tirzepatide 15mg

Tirzepatide 15mg is supplied for research protocols that require higher quantities of this dual incretin receptor agonist. Tirzepatide activates both GLP-1 and GIP pathways, and research has explored its effects on glucose-dependent insulin secretion, glucagon suppression, satiety signaling, and lipid metabolism.

Independently HPLC and MS/MS tested to 99%+ purity. COA included.

For research use only. Not for human or veterinary consumption.